HomeCompareQCXGF vs PFE

QCXGF vs PFE: Dividend Comparison 2026

QCXGF yields 1365.19% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QCXGF wins by $298822034.23M in total portfolio value
10 years
QCXGF
QCXGF
● Live price
1365.19%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$298822034.28M
Annual income
$261,186,648,013,879.53
Full QCXGF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — QCXGF vs PFE

📍 QCXGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQCXGFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QCXGF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QCXGF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QCXGF
Annual income on $10K today (after 15% tax)
$116,040.96/yr
After 10yr DRIP, annual income (after tax)
$222,008,650,811,797.60/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, QCXGF beats the other by $222,008,650,789,477.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QCXGF + PFE for your $10,000?

QCXGF: 50%PFE: 50%
100% PFE50/50100% QCXGF
Portfolio after 10yr
$149411017.16M
Annual income
$130,593,324,020,069.12/yr
Blended yield
87.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

QCXGF
No analyst data
Altman Z
4.9
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QCXGF buys
0
PFE buys
0
No recent congressional trades found for QCXGF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQCXGFPFE
Forward yield1365.19%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$298822034.28M$49.6K
Annual income after 10y$261,186,648,013,879.53$26,258.71
Total dividends collected$296055184.59M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: QCXGF vs PFE ($10,000, DRIP)

YearQCXGF PortfolioQCXGF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$147,219$136,518.77$9,153$693.39+$138.1KQCXGF
2$2,035,854$1,878,329.51$8,593$849.25+$2.03MQCXGF
3$26,454,041$24,275,677.50$8,336$1,066.78+$26.45MQCXGF
4$323,109,610$294,803,786.79$8,437$1,384.80+$323.10MQCXGF
5$3,710,898,270$3,365,170,987.26$9,013$1,875.40+$3710.89MQCXGF
6$40,091,059,516$36,120,398,366.33$10,306$2,680.72+$40091.05MQCXGF
7$407,598,672,629$364,701,238,947.34$12,820$4,101.38+$407598.66MQCXGF
8$3,901,413,421,656$3,465,282,841,943.19$17,673$6,826.70+$3901413.40MQCXGF
9$35,173,258,191,565$30,998,745,830,392.96$27,543$12,591.86+$35173258.16MQCXGF
10$298,822,034,278,854$261,186,648,013,879.53$49,560$26,258.71+$298822034.23MQCXGF

QCXGF vs PFE: Complete Analysis 2026

QCXGFStock

QcX Gold Corp. engages in the acquisition, exploration, and development of mineral properties in Mexico. It explores for gold and volcanic massive sulphide deposits. The company holds 100% interests in the Golden Giant project that covers approximately 18,992 hectares located in the James Bay region; and Kali project covering an area of approximately 10,127 hectares located in the James Bay lowlands area of Quebec. It also has an option agreement to acquire 100% interest the Fernet property that covers an area of 4,480 hectares located in the northern Abitibi region of Quebec. The company was formerly known as First Mexican Gold Corp. and changed its name to QcX Gold Corp. in July 2020. QcX Gold Corp. was incorporated in 2007 and is headquartered in Toronto, Canada.

Full QCXGF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this QCXGF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QCXGF vs SCHDQCXGF vs JEPIQCXGF vs OQCXGF vs KOQCXGF vs MAINQCXGF vs JNJQCXGF vs MRKQCXGF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.